心脏再同步治疗：现代神话是否阻碍了其合理应用？ - Suppr

Suppr

超能文献

Cardiac resynchronization therapy: are modern myths preventing appropriate use?

作者信息

Cleland John G F, Tavazzi Luigi, Daubert Jean-Claude, Tageldien Ahmed, Freemantle Nick

机构信息

Department of Cardiology, Castle Hill Hospital, Kingston upon Hull, United Kingdom.

IRCCS Policlinico S. Matteo, Pavia, Italy.

出版信息

J Am Coll Cardiol. 2009 Feb 17;53(7):608-611. doi: 10.1016/j.jacc.2008.10.040.

DOI:10.1016/j.jacc.2008.10.040

PMID:19215836

Abstract

摘要

相似文献

Cardiac resynchronization therapy: are modern myths preventing appropriate use?心脏再同步治疗：现代神话是否阻碍了其合理应用？

J Am Coll Cardiol. 2009 Feb 17;53(7):608-611. doi: 10.1016/j.jacc.2008.10.040.

[Cardiac resynchronization therapy in chronic heart failure].

Praxis (Bern 1994). 2007 Mar 14;96(11):421-2. doi: 10.1024/1661-8157.96.11.421.

[Modern pacemaker therapy].[现代起搏器治疗]

Duodecim. 2010;126(7):757-63.

Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.在无室性心律失常的心力衰竭患者中使用器械治疗降低死亡率。

Am J Crit Care. 2008 Sep;17(5):443-52; quiz 453.

[Non-pharmacological therapy of decompensated heart failure: cardiac resynchronization therapy].失代偿性心力衰竭的非药物治疗：心脏再同步治疗

G Ital Cardiol (Rome). 2008 Oct;9(10 Suppl 1):123S-128S.

[Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].具备双心室起搏功能的植入式自动除颤器的适应证及潜在益处

Ital Heart J Suppl. 2001 Dec;2(12):1308-14.

[Arrhythmia risk stratification in patients with heart failure. Foreword].[心力衰竭患者的心律失常风险分层。前言]

Ital Heart J Suppl. 2001 Dec;2(12):1263-4.

Sudden death prophylaxis in heart failure.心力衰竭的猝死预防

Int J Cardiol. 2007 Jul 31;119(3):291-6. doi: 10.1016/j.ijcard.2006.11.021. Epub 2007 Jan 17.

Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.植入式心脏复律除颤器（ICD）及心脏再同步治疗预防心源性猝死的适应证

Expert Rev Cardiovasc Ther. 2009 Feb;7(2):181-95. doi: 10.1586/14779072.7.2.181.

Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.由于起搏诱导性心肌病而升级为心脏再同步治疗的患者发生危及生命的室性心律失常的风险较低：一项长期死因分析。

Europace. 2018 Jan 1;20(1):89-96. doi: 10.1093/europace/euw321.

引用本文的文献

RELEASE-HF study: a protocol for an observational, registry-based study on the effectiveness of telemedicine in heart failure in the Netherlands.RELEASE-HF 研究：一项基于观察性注册研究的方案，旨在评估荷兰远程医疗在心力衰竭中的有效性。

BMJ Open. 2024 Jan 4;14(1):e078021. doi: 10.1136/bmjopen-2023-078021.

Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials.植入式血流动力学远程监测设备指导心力衰竭管理：随机试验的回顾和荟萃分析。

Clin Res Cardiol. 2023 Aug;112(8):1007-1019. doi: 10.1007/s00392-022-02104-0. Epub 2022 Oct 14.

Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.利尿剂治疗作为射血分数降低的心力衰竭患者临床试验的预后富集因素。

Clin Res Cardiol. 2021 Aug;110(8):1308-1320. doi: 10.1007/s00392-021-01851-w. Epub 2021 May 6.

Development and course of heart failure after a myocardial infarction in younger and older people.年轻人和老年人心肌梗死后心力衰竭的发展和进程。

J Geriatr Cardiol. 2014 Mar;11(1):1-12. doi: 10.3969/j.issn.1671-5411.2014.01.002.

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.一项针对五个随机试验的个体患者荟萃分析，评估心脏再同步治疗对有症状心力衰竭患者的发病率和死亡率的影响。

Eur Heart J. 2013 Dec;34(46):3547-56. doi: 10.1093/eurheartj/eht290. Epub 2013 Jul 29.

How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?如何改善预后：我们是否应该更加重视编程和医疗护理，而减少对患者选择的重视？

Heart Fail Rev. 2012 Nov;17(6):791-802. doi: 10.1007/s10741-012-9351-x.

The determinants of clinical outcome and clinical response to CRT are not the same.临床结局和 CRT 临床反应的决定因素并不相同。

Heart Fail Rev. 2012 Nov;17(6):755-66. doi: 10.1007/s10741-011-9268-9.

Increasing knowledge and changing views in cardiac resynchronization therapy.心脏再同步治疗领域不断增长的知识与不断变化的观点。

Heart Fail Rev. 2012 Nov;17(6):721-5. doi: 10.1007/s10741-011-9281-z.

Ventricular resynchronization is the principle mechanism of benefit with cardiac resynchronization therapy.心室再同步化是心脏再同步治疗获益的主要机制。

Heart Fail Rev. 2012 Nov;17(6):737-46. doi: 10.1007/s10741-011-9274-y.

Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.左心室机械不同步与 QRS 波群狭窄的心力衰竭患者心脏再同步治疗反应的相关性。

Eur Heart J. 2010 Dec;31(24):3054-62. doi: 10.1093/eurheartj/ehq334. Epub 2010 Sep 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验